GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Effective Interest Rate on Debt %

Beta Drugs (NSE:BETA) Effective Interest Rate on Debt % : 21.64% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Beta Drugs's annualized positive value of Interest Expense for the quarter that ended in Sep. 2024 was ₹37 Mil. Beta Drugs's average total debt for the quarter that ended in Sep. 2024 was ₹169 Mil. Therefore, Beta Drugs's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 was 21.64%.


Beta Drugs Effective Interest Rate on Debt % Historical Data

The historical data trend for Beta Drugs's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Effective Interest Rate on Debt % Chart

Beta Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.79 11.09 9.40 11.14 15.28

Beta Drugs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.60 12.68 15.33 17.35 21.64

Competitive Comparison of Beta Drugs's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beta Drugs's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Effective Interest Rate on Debt % falls into.


;
;

Beta Drugs Effective Interest Rate on Debt % Calculation

Beta Drugs's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Mar. 2023 )+Total Debt  (A: Mar. 2024 ))/ count )
=-1  *  -26.774/( (203.325+147.108)/ 2 )
=-1  *  -26.774/175.2165
=15.28 %

where

Total Debt  (A: Mar. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=69.738 + 133.587
=203.325

Total Debt  (A: Mar. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=60.407 + 86.701
=147.108

Beta Drugs's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Mar. 2024 )+Total Debt  (Q: Sep. 2024 ))/ count )
=-1  *  -36.542/( (147.108+190.596)/ 2 )
=-1  *  -36.542/168.852
=21.64 %

where

Total Debt  (Q: Mar. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=60.407 + 86.701
=147.108

Total Debt  (Q: Sep. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=101.731 + 88.865
=190.596

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Sep. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Beta Drugs  (NSE:BETA) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Beta Drugs Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beta Drugs Business Description

Industry
Traded in Other Exchanges
N/A
Address
SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines